DHARMAJNSEDharmaj Crop Guard Limited· Fertilizers & AgrochemicalsHighNeutral
Announced Tue, 10 Feb, 2026 · 17:49 IST

Dharmaj Crop Guard Q3 FY26 results: 9M revenue up 22%, PAT jumps 36%

Revenue Growth 20pctPat Growth 25pctResults View source PDFExplain this filing

DHARMAJ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.7%Reaction day
₹253.00
prior close
₹245.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-4.2% vs market
Pesticides & Agrochemicals peers, median of 26sector-1.1%-3.6% vs sector

On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 3.6 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.7
10m
-2.6
15m
-1.5
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.7-0.5-4.2-1.1-3.6
Next day
-5.1-1.0-4.1-0.5-4.6
2d
-5.1-2.5-2.7-3.0-2.2
3d
-8.3-3.2-5.1-2.8-5.5
4d
-7.0-2.2-4.8-2.7-4.2
5d
-7.0-1.9-5.1-3.0-4.0
1w
-7.0-3.5-3.5-4.4-2.6
15d
-5.1-8.8+3.7-10.5+5.4
1m
-4.7-9.3+4.5-12.2+7.4
2m
+9.1-4.5+13.6-10.0+19.1
3m
+3.3+5.4-2.0-2.9+6.2
UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dharmaj Crop Guard posted Q3 FY26 revenue of Rs 1,895.4M, up 8.6% YoY, but PAT fell to Rs 7.56M from Rs 11.79M. For nine months, revenue grew 22% to Rs 9,041.9M and PAT jumped 36% to Rs 506.8M. Nine month EPS rose to Rs 14.99 from Rs 11.03. Board approved standalone and consolidated results on Feb 10, 2026. Company is planning a new wholly owned subsidiary in Brazil. No stock options granted yet under ESOP 2023 scheme.

Likely market impact

Strong 9M performance with revenue and PAT both growing over 20%. Q3 was weak but overall full-year trajectory stays positive. Brazil expansion signals growth push.